Accessing a verified Dermorphin COA is essential for quantitative neurochemical and receptor binding assays. This reference guide details the analytical criteria, reverse-phase HPLC purity standards, electrospray mass spectrometry mass confirmation, and endotoxin thresholds required for rigorous laboratory research.
Accessing a verified Dermorphin COA is essential for quantitative neurochemical and receptor binding assays. This reference guide details the analytical criteria, reverse-phase HPLC purity standards, electrospray mass spectrometry mass confirmation, and endotoxin thresholds required for rigorous laboratory research.
A Dermorphin COA (Certificate of Analysis) is an authoritative quality document issued by an independent ISO 17025-accredited laboratory confirming the identity, purity, molecular mass, and bioburden of a specific peptide synthesis lot. For modern biochemical investigation, relying on standardized batch documentation ensures that experimental outcomes are attributable solely to the target peptide structure rather than synthetic truncations or chemical contaminants.
A compliant Certificate of Analysis for Dermorphin must detail key analytical metrics, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, net peptide content via nitrogen analysis, and Bacterial Endotoxin Testing (BET) via the Limulus Amebocyte Lysate (LAL) assay. Obtaining verified lot-specific testing ensures consistent receptor interaction dynamics across longitudinal bench trials.
Dermorphin is a natural heptapeptide originally isolated from the skin of South American frogs belonging to the *Phyllomedusa* genus. Its primary amino acid sequence is H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 (molecular formula: C40H50N8O10, monoisotopic mass: 802.37 Da). The defining structural characteristic of dermorphin is the inclusion of D-alanine at position 2, an unusual post-translational modification in animal-derived peptides that confers exceptional resistance to enzymatic cleavage by aminopeptidases.
In preclinical model systems, dermorphin demonstrates high selectivity and potent binding affinity for the mu-opioid receptor (MOR) compared to delta-opioid (DOR) and kappa-opioid (KOR) subtypes. Researchers utilize this compound in research peptides protocols evaluating signal transduction, G-protein coupling, beta-arrestin recruitment, and central nervous system nociceptive pathways in vitro and in animal models.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold-standard method for quantifying peptide purity on a Certificate of Analysis. During HPLC analysis, the sample is passed through a C18 stationary column using an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (TFA) as an ion-pairing agent. Ultraviolet detection at 214 nm and 220 nm measures the peptide backbone absorbance.
A valid Dermorphin COA must demonstrate a single prominent peak with a baseline-resolved area percentage exceeding 98.0%. Minor secondary peaks indicate synthetic impurities, such as deletion sequences (missing an amino acid step during solid-phase peptide synthesis), racemized isomers, or residual protecting groups (e.g., t-Bu, Pbf). High purity ensures that observed pharmacological responses are not altered by competitive binding from truncated peptide fragments.
While RP-HPLC establishes chemical purity, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms molecular identity by measuring the exact mass-to-charge ratio (m/z) of the molecule. The theoretical monoisotopic mass of dermorphin is 802.37 g/mol.
In ESI-MS spectral analysis, the principal observed signal typically corresponds to the protonated molecular ion [M+H]+ at m/z ~803.4, alongside potential doubly charged ions [M+2H]2+ depending on ionization conditions. A comprehensive COA presents the full mass spectrum, verifying that the observed molecular weight matches the theoretical target within a tight tolerance (typically ±0.5 Da), proving correct full-length synthesis.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—can confound cell culture assays and animal studies by inducing inflammatory cytokine cascades independent of opioid receptor activation. Consequently, endotoxin testing is a critical line item on any research-grade COA.
PX1 Research enforces strict bioburden testing using standardized LAL chromogenic methods. For high-grade laboratory reagents, endotoxin levels are held below 0.05 EU/mg. Evaluating these metrics through our central research hub protocols guarantees that cellular responses reflect pure mu-opioid signaling without background immune activation caused by pyrogens.
To contextualize dermorphin within neuropharmacological literature, researchers frequently compare its selectivity profile, enzymatic stability, and binding kinetics against other opioid-active sequences. The presence of D-amino acid substitutions is a shared design feature across several synthetic and natural analogs developed for receptor mapping.
While dermorphin is highly selective for mu-opioid sites, compounds like deltorphin II exhibit profound selectivity for delta-opioid receptors. Similarly, the synthetic enkephalin analog dalargin incorporates D-Ala to enhance enzymatic stability while targeting peripheral receptors. Studies using dadle guide protocols also highlight how altered peptide backbones shift mu/delta binding ratios. Comparing these compounds allows investigators to isolate receptor-specific signaling pathways in competitive binding assays.
Dermorphin is supplied as a lyophilized (freeze-dried) powder to maximize shelf life and stability. For laboratory preparation, the cake should be reconstituted using sterile, deionized water or bacteriostatic water, depending on the assay design. If necessary, gentle sonication or the addition of dilute acetic acid (0.1%) can assist in solubilizing stubborn hydrophobic preparations.
Once reconstituted, stock solutions should be divided into single-use working aliquots and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles. Lyophilized vials should be maintained at -20°C in a desiccated environment away from direct light. Following standardized laboratory handling preserves peptide integrity prior to binding kinetic measurements.
Evaluating supplier quality requires transparent documentation and standardized production controls. PX1 Research produces peptides in US-based, GMP-compliant facilities utilizing automated solid-phase peptide synthesis (SPPS) equipment. Every batch undergoes third-party verification through independent ISO 17025 accredited analytical laboratories.
We provide fully traceable, lot-specific Certificates of Analysis for every shipped vial. Laboratories sourcing through our wholesale program receive full documentation packages detailing raw analytical data, ensuring complete compliance for institutional research and peer-reviewed publication standards.
What information should I look for on a Dermorphin COA?
A comprehensive Dermorphin COA should display RP-HPLC purity percentage (>98%), ESI-MS spectrum confirming the 802.4 Da molecular mass, net peptide content, lot number, manufacture date, and bacterial endotoxin test results (<0.05 EU/mg).
How does HPLC verify Dermorphin purity?
RP-HPLC separates the main peptide from synthetic impurities based on hydrophobic interactions. The COA provides a chromatogram where the relative area of the primary dermorphin peak relative to total integrated peak area defines the purity percentage.
Why is D-Ala2 important in Dermorphin structural validation?
The D-alanine at position 2 protects dermorphin against aminopeptidase degradation in biological matrices. MS and chromatographic testing confirm that the synthesized peptide retains correct stereochemistry and structural integrity.
What is the expected molecular weight of Dermorphin on a mass spec report?
The theoretical monoisotopic mass of dermorphin is approximately 802.37 Da. ESI-MS reports on the COA will display a dominant protonated mass peak ([M+H]+) around 803.4 m/z.
What solvent is recommended for reconstituting lyophilized Dermorphin?
Dermorphin is typically soluble in sterile water or phosphate-buffered saline (PBS, pH 7.4). For long-term stock preservation, non-pyrogenic sterile water is recommended before diluting into final assay buffers.
How are endotoxin limits measured for research peptides?
Endotoxin levels are quantified using the Limulus Amebocyte Lysate (LAL) enzymatic assay. High-purity laboratory batches maintain endotoxin thresholds under 0.05 EU/mg to avoid confounding cell culture or animal assays.
Where are PX1 Research peptides synthesized and tested?
All PX1 Research peptides are manufactured in US-based GMP-compliant facilities and undergo independent testing at ISO 17025 accredited laboratories in the United States.
Can Dermorphin be used for human consumption or therapeutic testing?
No. Dermorphin is strictly sold as a research chemical for in vitro laboratory experiments and preclinical scientific studies. It is not for human or veterinary medical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.